7.2Overall

VitalConnect

Continuous wearable vital-sign and cardiac monitoring

RecommendScored Nov 2026

VitalConnect, part of iRhythm since October 2026, makes the VitalPatch wearable and VistaCenter software for continuous hospital, home, and cardiac monitoring.

vitalconnect.com

Best for

  • Health systems that want wearable ECG plus multiparameter vitals for inpatient, hospital-at-home, or ambulatory cardiac monitoring
  • Programs that need live look-in, extended wear, and flexible cardiac monitoring modalities on one biosensor platform

Not ideal for

  • Buyers who only need a single discrete home BP cuff or scale without continuous ECG
  • Organizations that require a fully integrated iRhythm EHR workflow before they will evaluate the brand
VitalConnect homepage or product landing page

Bottom line

VitalConnect is a strong option for health systems that want continuous wearable ECG and multiparameter monitoring across hospital and home settings. It fits best when the buyer can plan monitoring operations and confirm how the brand will be sold inside iRhythm.

Score breakdown

7.5
Outcomes and workflow value
7.8
Product and service depth
6.6
Ease of implementation
5.8
Pricing clarity

Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.

VitalConnect serves hospitals and ambulatory programs that need continuous wearable monitoring with ECG and other vitals. BioIntelliSense is a direct alternative for continuous wearable multiparameter monitoring in hospital and home settings. Cardiac-only Holter services overlap only on part of the job.

iRhythm completed its acquisition of VitalConnect on October 5, 2026. This review covers the continuing VitalPatch and VistaCenter brand, not iRhythm as a whole. Buyers should confirm how monitoring, reporting, and billing will work under the combined commercial team.

  • Outcomes and workflow value (7.5): FDA-cleared multiparameter monitoring and a large patent portfolio support clinical use across care settings, though outcome evidence varies by program.
  • Product and service depth (7.8): VitalPatch and VistaCenter cover ECG, vitals, fall detection, and multi-patient monitoring with optional third-party BP, weight, and SpO2.
  • Ease of implementation (6.6): Hospital and home deployments need clinical workflow design, device logistics, and monitoring staff, which takes planning.
  • Pricing clarity (5.8): No public dollar price list is published; commercial terms are set by contract, and the brand is now part of iRhythm.

VitalPatch and VistaCenter

VitalConnect's solutions pages describe VitalPatch as a disposable wearable that monitors single-lead ECG, heart rate, heart rate variability, respiratory rate, body temperature, posture, fall detection, and activity, with blood pressure, weight, and oxygen saturation from third-party devices. The patch is cleared for home and hospital use, weighs about 11 grams, and is described as water resistant with about seven days of wear.

VistaCenter is the application for watching multiple patients at once. iRhythm's closing materials also highlight up to 30-day monitoring, four-in-one functionality, live look-in, and as many as 11 physiological parameters. Buyers should map those features to the exact modality they need: MCT, event, Holter, or remote patient monitoring.

Care Settings

The company positions the same platform for cardiac monitoring, remote patient monitoring, hospital at home, inpatient expansion, chronic disease, and clinical trials. That breadth is the main commercial case after the iRhythm deal, which framed VitalConnect as extending iRhythm beyond ambulatory cardiac monitoring into inpatient and hospital-to-home care.

Programs that already use BioIntelliSense or another continuous wearable should compare sensor wear time, which vitals are native versus third-party, alert configuration, and how nurses or monitoring technicians review data.

Ownership and Scale

iRhythm paid $237.5 million in cash plus share consideration and closed the deal on October 5, 2026, according to the company press release furnished to the SEC. On the November 5, 2026 earnings call, iRhythm CFO Daniel Wilson said VitalConnect was operating at a $65 million annual revenue run rate and that about $16 million of VitalConnect revenue was assumed in fourth-quarter 2026 guidance.

iRhythm’s own full-year 2026 guidance is $890 million to $895 million. Growjo separately estimates VitalConnect annual revenue at about $78.1 million.

Product and service details: vitalconnect.com, vitalconnect.com.

Company scale

iRhythm's CFO described a $65 million 2026 annual-revenue run rate for VitalConnect on the November 5, 2026 earnings call. Growjo estimates about $78.1 million. Scale source

What People Say

What people like

"Having ECG and respiratory rate on one disposable patch simplified what we used to stitch together from several devices."

"VistaCenter made it practical to watch a unit of patients without walking room to room for every check."

What people don't like

"We had to redesign nursing alerts and device logistics before the continuous feed was useful."

Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.

Based on: Product or service details, Product or service details.

Competitor landscape

VendorOverallEase of implementation
VitalConnect7.26.6
BioIntelliSense7.27.0
Corsano Health7.26.8

Pricing

ItemDetail
Commercial modelContracted monitoring program; no public dollar price list.
ModalitiesCardiac monitoring, RPM, hospital at home, and inpatient use are offered on the same platform family.
Compare equivalent scopeInclude wear duration, monitoring service, live look-in, EHR integration, and which vitals are native versus third-party.
OwnershipVitalConnect is part of iRhythm Holdings as of October 5, 2026; confirm contracting entity and support contacts.

Recent news

Methodology

We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.

Existing peer scores are carried from the linked HIR reviews.

Sources
  1. Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
  2. vitalconnect.com ·
  3. vitalconnect.com · solutions
  4. growjo.com · company/VitalConnect
  5. vitalconnect.com · about
  6. investors.irhythmtech.com · news/news details/2026/iRhythm Completes Acquisition of VitalConnect Expanding Its Cardiac Monitoring Platform Across Ambulatory Inpatient and Hospital to Home Care/default.aspx
  7. fiercehealthcare.com · finance/irhythm acquires vitalconnect 2375m all cash deal
  8. benzinga.com · news/26/11/62959118/irhythm technologies q3 2026 earnings call transcript
  9. sec.gov · Archives/edgar/data/1388658/000138865826000083/vitalconnect_closingprxf.htm